Revenue (Annual) Chart

View Revenue (Annual) for UFPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1995. Start Trial.
Date Value
December 31, 2025 602.80M
December 31, 2024 504.42M
December 31, 2023 400.07M
December 31, 2022 353.79M
December 31, 2021 206.32M
December 31, 2020 179.37M
December 31, 2019 198.38M
December 31, 2018 190.46M
December 31, 2017 147.84M
December 31, 2016 146.13M
December 31, 2015 138.85M
December 31, 2014 139.31M
December 31, 2013 139.22M
December 31, 2012 130.96M
December 31, 2011 127.24M
December 31, 2010 120.77M
Date Value
December 31, 2009 99.23M
December 31, 2008 110.03M
December 31, 2007 93.60M
December 31, 2006 93.75M
December 31, 2005 83.96M
December 31, 2004 68.62M
December 31, 2003 60.90M
December 31, 2002 61.19M
December 31, 2001 61.57M
December 31, 2000 74.49M
December 31, 1999 58.80M
December 31, 1998 47.22M
December 31, 1997 45.45M
December 31, 1996 39.36M
December 31, 1995 34.10M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Abbott Laboratories 44.33B
AngioDynamics, Inc. 320.17M
Alphatec Holdings, Inc. 764.16M
AtriCure, Inc. 534.53M
Baxter International, Inc. 11.24B